We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Levels of 8-OxodG Predict Hepatobiliary Pathology in Opisthorchiasis

By LabMedica International staff writers
Posted on 19 Aug 2015
Opisthorchis viverrini is distinct among helminth infections as it drives a chronic inflammatory response in the intrahepatic bile duct that progresses from advanced periductal fibrosis (APF) to cholangiocarcinoma (CCA).

Oxidative stress (OS) plays a critical role in the transition from chronic O. More...
viverrini infection to CCA and also results in the excision of a modified DNA lesion 8-oxodG into urine, the levels of which can be detected by immunoassay.

Scientists at Khon Kaen University (Thailand) and an international team of collaborators, assigned 149 individuals to three groups; Group 1 were 23 individuals negative (uninfected) upon fecal examination for O. viverrini; Group 2 were 48 O. viverrini positive (OV+) individuals who were negative for APF; and Group 3 were 78 O. viverrini positive individuals who were also positive for APF. Group 4 consists of samples from 33 individuals who had histologically proven O. viverrini-associated CCA, whose urine samples had been stored.

Venous blood samples were collected from individuals in Groups 1, 2 and 3, into siliconized tubes after overnight fasting. Venous blood samples were allowed to clot at room temperature for 30 minutes after collection, centrifuged, and the serum recovered. An enzyme-linked immunosorbent assay (ELISA) was used to quantify levels of the antibody against O. viverrini antigen in serum. Concentration of 8-oxodG in urine was measured using a validated competitive ELISA kit (HT Trevigen, Gaithersburg, MD, USA). The ELISA plates were read using a SpectraMax 340PC384 microplate reader (Molecular Devices, Sunnydale, CA, USA).

Elevated concentrations of 8-oxodG in urine was positively associated with APF and CCA in a strongly dose-dependent manner. Urinary 8-oxodG concentrations also accurately predicted whether an individual presented with APF or CCA compared to O. viverrini infected individuals without these pathologies. Urinary 8-oxodG is a robust candidate biomarker of the progression of APF and CCA from chronic opisthorchiasis, which is indicative of the critical role that OS plays in both of these advanced hepatobiliary pathologies.

The authors confirmed their previous observations that severe liver pathology occurs early and asymptomatically in residents of O. viverrini endemic regions, where individuals are infected for years and often decades with this food-borne pathogen. These findings also contribute to an expanding literature on 8-oxodG in an easily accessible bodily fluid as in urine, as a biomarker in the multistage process of inflammation, fibrogenesis, and infection-induced cancer. O. viverrini is commonly known as the Southeast Asian liver fluke. The study was published on July 31, 2015, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

Khon Kaen University 
HT Trevigen 
Molecular Devices 



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Modular Hemostasis Automation Solution
CN Track
New
PlGF Test
Quidel Triage PlGF Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.